NCT03162198View on ClinicalTrials.gov

Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

Cirrhosis with HCC

Cirrhosis with Hepatocellular Carcinoma

OTHER

Cirrhosis without HCC

Cirrhosis without Hepatocellular Carcinoma

Trial Locations (1)

110070

Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT03162198 - Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) | Biotech Hunter | Biotech Hunter